Venlafaxine Hydrochloride Patent Expiration
Venlafaxine Hydrochloride is Used for treating depression, generalized anxiety disorder, panic disorder, and social anxiety disorder. It was first introduced by Wyeth Pharmaceuticals Inc
Venlafaxine Hydrochloride Patents
Given below is the list of patents protecting Venlafaxine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Effexor Xr |
US6274171 (Pediatric) | Extended release formulation of venlafaxine hydrochloride |
Sep 20, 2017
(Expired) | Upjohn |
Effexor Xr |
US6403120 (Pediatric) | Extended release formulation of venlafaxine hydrochloride |
Sep 20, 2017
(Expired) | Upjohn |
Effexor Xr |
US6419958 (Pediatric) | Extended release formulation of venlafaxine hydrochloride |
Sep 20, 2017
(Expired) | Upjohn |
Effexor Xr | US6274171 | Extended release formulation of venlafaxine hydrochloride |
Mar 20, 2017
(Expired) | Upjohn |
Effexor Xr | US6403120 | Extended release formulation of venlafaxine hydrochloride |
Mar 20, 2017
(Expired) | Upjohn |
Effexor Xr | US6419958 | Extended release formulation of venlafaxine hydrochloride |
Mar 20, 2017
(Expired) | Upjohn |
Venlafaxine Hydrochloride | US6403120 | Extended release formulation of venlafaxine hydrochloride |
Mar 20, 2017
(Expired) | Osmotica Pharm Us |
Venlafaxine Hydrochloride | US6419958 | Extended release formulation of venlafaxine hydrochloride |
Mar 20, 2017
(Expired) | Osmotica Pharm Us |
Effexor Xr |
US5916923 (Pediatric) | Venlafaxine for the treatment of generalized anxiety disorder |
Dec 28, 2013
(Expired) | Upjohn |
Effexor Xr |
US6444708 (Pediatric) | Treatment using venlafaxine |
Dec 28, 2013
(Expired) | Upjohn |
Effexor Xr | US5916923 | Venlafaxine for the treatment of generalized anxiety disorder |
Jun 28, 2013
(Expired) | Upjohn |
Effexor Xr | US6310101 | Treatments using venlafaxine |
Jun 28, 2013
(Expired) | Upjohn |
Effexor Xr | US6444708 | Treatment using venlafaxine |
Jun 28, 2013
(Expired) | Upjohn |
Venlafaxine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Venlafaxine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Venlafaxine Hydrochloride. The first generic version for Venlafaxine Hydrochloride was by Teva Pharmaceuticals Usa Inc and was approved on Aug 3, 2006. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Jun 6, 2024.
Given below is the list of companies who have filed for Venlafaxine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 12, 2023 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 12, 2023 |
EQ 225MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 12, 2023 |
EQ 75MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 12, 2023 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
2. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Jun 6, 2024 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Jun 6, 2024 |
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Jun 6, 2024 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
3. ALEMBIC PHARMS LTD
Alembic Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Dec 14, 2010 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Dec 14, 2010 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Dec 14, 2010 |
EQ 37.5MG BASE | tablet | Prescription | ORAL | AB | Dec 14, 2010 |
EQ 75MG BASE | tablet | Prescription | ORAL | AB | Dec 14, 2010 |
4. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 10, 2021 |
EQ 75MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 10, 2021 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 10, 2021 |
EQ 225MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 10, 2021 |
5. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | May 11, 2010 |
EQ 37.5MG BASE | tablet | Discontinued | ORAL | N/A | May 11, 2010 |
EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | May 11, 2010 |
EQ 75MG BASE | tablet | Discontinued | ORAL | N/A | May 11, 2010 |
EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | May 11, 2010 |
6. ANCHEN PHARMS
Anchen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Anchen Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 75MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Mar 16, 2012 |
EQ 37.5MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Mar 16, 2012 |
EQ 150MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Mar 16, 2012 |
7. ANNORA PHARMA
Annora Pharma Private Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Annora Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Jul 8, 2019 |
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Jul 8, 2019 |
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Jul 8, 2019 |
Manufacturing Plant Locations New
Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
8. APPCO
Appco Pharma Llc has filed for 2 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Appco.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 225MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 30, 2021 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 30, 2021 |
Manufacturing Plant Locations New
Appco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Appco as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
|
9. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 75MG BASE | tablet, extended release | Prescription | ORAL | AB | Oct 21, 2020 |
EQ 225MG BASE | tablet, extended release | Prescription | ORAL | AB | Oct 21, 2020 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Oct 21, 2020 |
EQ 37.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Oct 21, 2020 |
10. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Apr 7, 2010 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Apr 7, 2010 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Apr 7, 2010 |
EQ 75MG BASE | tablet | Prescription | ORAL | AB | Apr 7, 2010 |
EQ 37.5MG BASE | tablet | Prescription | ORAL | AB | Apr 7, 2010 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||
United States |
|
11. AUROBINDO PHARMA LTD
Aurobindo Pharma Limited has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Apr 14, 2011 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Apr 14, 2011 |
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Apr 14, 2011 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
12. CADILA PHARMS LTD
Cadila Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cadila Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Nov 21, 2018 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Nov 21, 2018 |
EQ 37.5MG BASE | tablet | Prescription | ORAL | AB | Nov 21, 2018 |
EQ 75MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 29, 2019 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Nov 21, 2018 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 29, 2019 |
EQ 225MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 29, 2019 |
13. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 37.5MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 75MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
14. DEXCEL
Dexcel Pharma Technologies Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dexcel.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Oct 31, 2019 |
EQ 225MG BASE | tablet, extended release | Prescription | ORAL | AB | Oct 31, 2019 |
EQ 75MG BASE | tablet, extended release | Prescription | ORAL | AB | Jan 21, 2021 |
Manufacturing Plant Locations New
Dexcel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Dexcel as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
Israel |
|
15. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 6 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | May 6, 2011 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | May 6, 2011 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | May 6, 2011 |
16. GRANULES
Granules India Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Granules.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | May 18, 2023 |
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | May 18, 2023 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | May 18, 2023 |
Manufacturing Plant Locations New
Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.
Country | City | Firm Name | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||
India |
|
17. HERITAGE
Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Heritage.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Jan 9, 2009 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Jan 9, 2009 |
EQ 37.5MG BASE | tablet | Prescription | ORAL | AB | Jan 9, 2009 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Jan 9, 2009 |
EQ 75MG BASE | tablet | Prescription | ORAL | AB | Jan 9, 2009 |
Manufacturing Plant Locations New
Heritage's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
|
18. INTELLIPHARMACEUTICS
Intellipharmaceutics Corp has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Intellipharmaceutics.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Nov 23, 2018 |
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Nov 23, 2018 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Nov 23, 2018 |
Manufacturing Plant Locations New
Intellipharmaceutics's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Intellipharmaceutics as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
Canada |
|
19. INVENTIA HLTHCARE
Inventia Healthcare Private Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Inventia Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Mar 12, 2020 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Mar 12, 2020 |
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Mar 12, 2020 |
20. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Oct 5, 2017 |
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Oct 5, 2017 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Oct 5, 2017 |
21. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 6 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 37.5MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Jun 1, 2011 |
EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 75MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Jun 1, 2011 |
EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 150MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Jun 1, 2011 |
22. NOSTRUM LABS INC
Nostrum Laboratories Inc has filed for 2 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Mar 24, 2017 |
EQ 225MG BASE | tablet, extended release | Prescription | ORAL | AB | Mar 24, 2017 |
23. NOSTRUM PHARMS LLC
Nostrum Pharmaceuticals Llc has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Nostrum Pharms Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Apr 4, 2023 |
EQ 75MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Apr 4, 2023 |
EQ 150MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Apr 4, 2023 |
24. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Jul 11, 2011 |
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Jul 11, 2011 |
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Jul 11, 2011 |
25. PLIVA HRVATSKA DOO
Pliva Hrvatska Doo has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Pliva Hrvatska Doo.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 37.5MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 75MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Jun 13, 2008 |
26. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Prinston Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2010 |
EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2010 |
EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2010 |
EQ 75MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2010 |
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2010 |
27. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 150MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Aug 18, 2010 |
EQ 75MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Aug 18, 2010 |
EQ 37.5MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Aug 18, 2010 |
EQ 225MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jan 8, 2019 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||||||||||||
India |
|
28. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 37.5MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 75MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
29. SWISS PHARM
Swiss Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Swiss Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 75MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jan 4, 2022 |
EQ 150MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jan 4, 2022 |
Manufacturing Plant Locations New
Swiss Pharm's manufacturing plants are situated in 1 country - Taiwan. Given below are the details of these plant locations as well as the firm names of Swiss Pharm as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
Taiwan |
|
30. TEVA
Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Jun 28, 2010 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Aug 3, 2006 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Jun 28, 2010 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Aug 3, 2006 |
EQ 50MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Aug 3, 2006 |
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Jun 28, 2010 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
India |
| |||||||||
Canada |
| |||||||||
Czech Republic |
| |||||||||
Ireland |
| |||||||||
Israel |
|
31. TORRENT
Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Jun 1, 2011 |
EQ 75MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Jun 1, 2011 |
EQ 150MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Jun 1, 2011 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
Country | City | Firm Name | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||||
United States |
|
32. UNIQUE
Unique Pharmaceutical Laboratories A Div Of Jb Chemicals And Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Unique.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 75MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 28, 2022 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 28, 2022 |
EQ 225MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 28, 2022 |
EQ 37.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 28, 2022 |
Manufacturing Plant Locations New
Unique's manufacturing plants are situated in 5 countries - United States, India, Canada, Portugal, Taiwan. Given below are the details of these plant locations as well as the firm names of Unique as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||||||||||||||
India |
| |||||||||||||||||||||||||||||||
Canada |
| |||||||||||||||||||||||||||||||
Portugal |
| |||||||||||||||||||||||||||||||
Taiwan |
|
33. VALEANT PHARMS NORTH
Valeant Pharmaceuticals North America Llc has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Valeant Pharms North.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 75MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Apr 15, 2011 |
EQ 37.5MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Apr 15, 2011 |
EQ 150MG BASE | capsule, extended release | Discontinued | ORAL | N/A | Apr 15, 2011 |
34. WOCKHARDT BIO AG
Wockhardt Bio Ag has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Apr 14, 2011 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Apr 14, 2011 |
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Apr 14, 2011 |
35. YAOPHARMA CO LTD
Yaopharma Co Ltd has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Yaopharma Co Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 100MG BASE | tablet | Prescription | ORAL | AB | May 28, 2015 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | May 28, 2015 |
EQ 37.5MG BASE | tablet | Prescription | ORAL | AB | May 28, 2015 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | May 28, 2015 |
EQ 75MG BASE | tablet | Prescription | ORAL | AB | May 28, 2015 |
Manufacturing Plant Locations New
Yaopharma Co Ltd's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yaopharma Co Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
China |
|
36. YICHANG HUMANWELL
Yichang Humanwell Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Yichang Humanwell.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Aug 6, 2021 |
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Aug 6, 2021 |
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Aug 6, 2021 |
Manufacturing Plant Locations New
Yichang Humanwell's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yichang Humanwell as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
China |
|
37. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 225MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 30, 2022 |
EQ 37.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 30, 2022 |
EQ 75MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 30, 2022 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 30, 2022 |
38. ZYDUS PHARMS USA
Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 37.5MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 75MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Jun 13, 2008 |
39. ZYDUS PHARMS USA INC
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 37.5MG BASE | capsule, extended release | Prescription | ORAL | AB | Apr 14, 2011 |
EQ 75MG BASE | capsule, extended release | Prescription | ORAL | AB | Apr 14, 2011 |
EQ 150MG BASE | capsule, extended release | Prescription | ORAL | AB | Apr 14, 2011 |